Role of de novo lipogenesis in inflammation and insulin resistance in alzheimer's disease.

[1]  M. M. Khan.  Role of de novo lipogenesis in insulin resistance in first-episode psychosis and therapeutic options , 2022, Neuroscience & Biobehavioral Reviews.

[2]  B. Nordestgaard,et al.  Blood Leukocyte Counts in Alzheimer Disease , 2022, JAMA network open.

[3]  Hongyuan Yang,et al.  Hypoxia truncates and constitutively activates the key cholesterol synthesis enzyme squalene monooxygenase , 2022, bioRxiv.

[4]  S. Giunta,et al.  Hypoxia in Aging and Aging-Related Diseases: Mechanism and Therapeutic Strategies , 2022, International journal of molecular sciences.

[5]  Lieliang Zhang,et al.  Lipid metabolism and storage in neuroglia: role in brain development and neurodegenerative diseases , 2022, Cell & bioscience.

[6]  M. M. Khan.  Disrupted leptin-fatty acid biosynthesis is an early manifestation of metabolic abnormalities in schizophrenia , 2022, World journal of psychiatry.

[7]  L. Leach,et al.  Systemic Inflammation Predicts Alzheimer Pathology in Community Samples without Dementia , 2022, Biomedicines.

[8]  Jiansong Fang,et al.  Comparative Metabolomics Analysis Reveals Key Metabolic Mechanisms and Protein Biomarkers in Alzheimer’s Disease , 2022, Frontiers in Pharmacology.

[9]  H. Bellen,et al.  Neuronal ROS-induced glial lipid droplet formation is altered by loss of Alzheimer’s disease–associated genes , 2021, Proceedings of the National Academy of Sciences.

[10]  Yanjiang Wang,et al.  The Correlation of Tau Levels with Blood Monocyte Count in Patients with Alzheimer’s Disease , 2021, Journal of Alzheimer's Disease.

[11]  M. Baquero,et al.  Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages , 2021, Biomedicines.

[12]  D. A. Davies.  The Role of APOE and NF-κB in Alzheimer’s Disease , 2021, Immuno.

[13]  M. Synofzik,et al.  Intracellular Lipid Accumulation and Mitochondrial Dysfunction Accompanies Endoplasmic Reticulum Stress Caused by Loss of the Co-chaperone DNAJC3 , 2021, Frontiers in Cell and Developmental Biology.

[14]  P. Passmore,et al.  Lipid Profiling of Alzheimer’s Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism , 2021, Cells.

[15]  M. Haidar,et al.  Fatty Acid Synthesis in Glial Cells of the CNS , 2021, International journal of molecular sciences.

[16]  I. Fraser,et al.  Lipid regulation of NLRP3 inflammasome activity through organelle stress. , 2021, Trends in immunology.

[17]  C. Arias,et al.  Palmitic acid induces insulin resistance by a mechanism associated with energy metabolism and calcium entry in neuronal cells , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  Rik van der Kant,et al.  Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects , 2021, Frontiers in Aging Neuroscience.

[19]  D. Bennett,et al.  Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer’s disease , 2021, Nature Neuroscience.

[20]  V. Lowe,et al.  Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[21]  D. Borchelt,et al.  Reactive astrocytes as treatment targets in Alzheimer's disease—Systematic review of studies using the APPswePS1dE9 mouse model , 2021, Glia.

[22]  Daishi Tian,et al.  Microglia reprogram metabolic profiles for phenotype and function changes in central nervous system , 2021, Neurobiology of Disease.

[23]  Fan Wang,et al.  High-Throughput Metabolomics for Discovering Potential Biomarkers and Identifying Metabolic Mechanisms in Aging and Alzheimer’s Disease , 2020, Frontiers in Cell and Developmental Biology.

[24]  P. Delespaul,et al.  Dysregulated Lipid Metabolism Precedes Onset of Psychosis , 2020, Biological Psychiatry.

[25]  Brandon C Farmer,et al.  Lipid Droplets in Neurodegenerative Disorders , 2020, Frontiers in Neuroscience.

[26]  S. Craft,et al.  Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches , 2020, The Lancet Neurology.

[27]  G. Ateş,et al.  CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer's disease , 2020, Redox biology.

[28]  Jennifer G. Robinson,et al.  Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies , 2020, PLoS medicine.

[29]  D. Wilcock,et al.  The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer’s Disease , 2020, Frontiers in Immunology.

[30]  A. Markham.  Bempedoic Acid: First Approval , 2020, Drugs.

[31]  N. Toschi,et al.  A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease , 2020, Frontiers in Immunology.

[32]  J. Bogie,et al.  Fatty acid metabolism in the progression and resolution of CNS disorders. , 2020, Advanced drug delivery reviews.

[33]  Sang-Woo Lee,et al.  The effect of chronic cerebral hypoperfusion on the pathology of Alzheimer's disease: A positron emission tomography study in rats , 2019, Scientific Reports.

[34]  D. Praticò,et al.  Impaired mitochondrial calcium efflux contributes to disease progression in models of Alzheimer’s disease , 2019, Nature Communications.

[35]  H. Vinters,et al.  Apolipoprotein E/Amyloid-β Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4. , 2019, The American journal of pathology.

[36]  M. Meffert,et al.  Cellular Specificity of NF-κB Function in the Nervous System , 2019, Front. Immunol..

[37]  F. Tanaka,et al.  Microglia in Alzheimer's Disease: Risk Factors and Inflammation , 2018, Front. Neurol..

[38]  N. Müller.  Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations , 2018, Schizophrenia bulletin.

[39]  J. Hanson,et al.  Microglia in Alzheimer’s disease , 2018, The Journal of cell biology.

[40]  Steven E. Arnold,et al.  Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums , 2018, Nature Reviews Neurology.

[41]  A. Saykin,et al.  Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study , 2018, PLoS medicine.

[42]  R. González-Reyes,et al.  Involvement of Astrocytes in Alzheimer’s Disease from a Neuroinflammatory and Oxidative Stress Perspective , 2017, Front. Mol. Neurosci..

[43]  Yue-Ming Li,et al.  The role of astrocytes in amyloid production and Alzheimer's disease , 2017, Open Biology.

[44]  H. Bellen,et al.  The Glia-Neuron Lactate Shuttle and Elevated ROS Promote Lipid Synthesis in Neurons and Lipid Droplet Accumulation in Glia via APOE/D. , 2017, Cell metabolism.

[45]  R. Thangavel,et al.  Glia Maturation Factor and Mitochondrial Uncoupling Proteins 2 and 4 Expression in the Temporal Cortex of Alzheimer’s Disease Brain , 2017, Front. Aging Neurosci..

[46]  Y. An,et al.  Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study , 2017, PLoS medicine.

[47]  D. Ory,et al.  Fatty acid synthesis configures the plasma membrane for inflammation in diabetes , 2016, Nature.

[48]  M. Pilon.  Revisiting the membrane-centric view of diabetes , 2016, Lipids in Health and Disease.

[49]  Florian J. Gerich,et al.  Astroglial NF-kB contributes to white matter damage and cognitive impairment in a mouse model of vascular dementia , 2016, Acta neuropathologica communications.

[50]  Nick C Fox,et al.  Alzheimer's disease in the 100 years since Alzheimer's death. , 2015, Brain : a journal of neurology.

[51]  Seth Love,et al.  Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer's disease and vascular dementia. , 2015, Brain : a journal of neurology.

[52]  L. Tan,et al.  Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease. , 2015, Annals of translational medicine.

[53]  Chun-Yan Lim,et al.  Lipid-Overloaded Enlarged Adipocytes Provoke Insulin Resistance Independent of Inflammation , 2015, Molecular and Cellular Biology.

[54]  J. Bergquist,et al.  Palmitate-induced impairments of β-cell function are linked with generation of specific ceramide species via acylation of sphingosine. , 2015, Endocrinology.

[55]  N. J. Allen,et al.  Astrocytes Control Synapse Formation, Function, and Elimination. , 2015, Cold Spring Harbor perspectives in biology.

[56]  D. Nomura,et al.  Microglia dictate the impact of saturated fat consumption on hypothalamic inflammation and neuronal function. , 2014, Cell reports.

[57]  C. Kahn,et al.  Insulin Action in Brain Regulates Systemic Metabolism and Brain Function , 2014, Diabetes.

[58]  M. Golovko,et al.  Fatty acid biosynthesis from glutamate and glutamine is specifically induced in neuronal cells under hypoxia , 2014, Journal of neurochemistry.

[59]  Chun-ling Dai,et al.  Chronic cerebral hypoperfusion causes decrease of O-GlcNAcylation, hyperphosphorylation of tau and behavioral deficits in mice , 2014, Front. Aging Neurosci..

[60]  Ken D. Stark,et al.  Microglial Cell Activation Increases Saturated and Decreases Monounsaturated Fatty Acid Content, but Both Lipid Species are Proinflammatory , 2014, Lipids.

[61]  H. Eltzschig,et al.  Hypoxia and inflammation are two sides of the same coin , 2013, Proceedings of the National Academy of Sciences.

[62]  Huaxi Xu,et al.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy , 2013, Nature Reviews Neurology.

[63]  J. Schneider,et al.  Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. , 2012, The Journal of clinical investigation.

[64]  S. M. de la Monte.  Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease , 2012, Current Alzheimer research.

[65]  H. Vinters,et al.  Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases. , 2012, Journal of Alzheimer's disease : JAD.

[66]  J. Growdon,et al.  Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease. , 2011, The American journal of pathology.

[67]  G. Schmitz,et al.  Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes , 2010, Proceedings of the National Academy of Sciences.

[68]  C. Gong,et al.  Deregulation of sphingolipid metabolism in Alzheimer's disease , 2010, Neurobiology of Aging.

[69]  M. Piccinini,et al.  Deregulated Sphingolipid Metabolism and Membrane Organization in Neurodegenerative Disorders , 2010, Molecular Neurobiology.

[70]  Fang Yu,et al.  Palmitic acid mediates hypothalamic insulin resistance by altering PKC-theta subcellular localization in rodents. , 2009, The Journal of clinical investigation.

[71]  D. Holtzman,et al.  The Role of Apolipoprotein E in Alzheimer's Disease , 2009, Neuron.

[72]  Wei⁃qin Zhao,et al.  Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease. , 2009, Biochimica et biophysica acta.

[73]  A. Kennedy,et al.  Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications. , 2009, The Journal of nutrition.

[74]  J. Girard,et al.  Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. , 2008, The Journal of clinical investigation.

[75]  V. Haroutunian,et al.  Gene Expression Alterations in the Sphingolipid Metabolism Pathways during Progression of Dementia and Alzheimer’s Disease: A Shift Toward Ceramide Accumulation at the Earliest Recognizable Stages of Alzheimer’s Disease? , 2007, Neurochemical Research.

[76]  K. Kristensson,et al.  Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease , 1991, Lipids.

[77]  N. Schuff,et al.  Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. , 2005, Radiology.

[78]  D. Bennett,et al.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. , 2004, Archives of neurology.

[79]  M. Mattson,et al.  Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[80]  D. Ferriero,et al.  Hypoxia increases calcium flux through cortical neuron glutamate receptors via protein kinase C , 2003, Journal of neurochemistry.

[81]  V. Parikh,et al.  Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics , 2002, Schizophrenia Research.

[82]  Xianlin Han,et al.  Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis , 2002, Journal of neurochemistry.

[83]  V. Haroutunian,et al.  Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. , 2000, Archives of neurology.

[84]  R. Martins,et al.  Insulin Effects on Glucose Metabolism, Memory, and Plasma Amyloid Precursor Protein in Alzheimer's Disease Differ According to Apolipoprotein‐E Genotype , 2000, Annals of the New York Academy of Sciences.

[85]  R. Martins,et al.  The effect of insulin and glucose on the plasma concentration of Alzheimer's amyloid precursor protein , 1999, Neuroscience.

[86]  Sanjay Asthana,et al.  Insulin Metabolism in Alzheimer’s Disease Differs According to Apolipoprotein E Genotype and Gender , 1999, Neuroendocrinology.

[87]  T. Kircher,et al.  Cognitive decline unlike normal aging is associated with alterations of EEG temporo-spatial characteristics , 1998, European Archives of Psychiatry and Clinical Neuroscience.

[88]  M. Katan,et al.  Impact of myristic acid versus palmitic acid on serum lipid and lipoprotein levels in healthy women and men. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[89]  H. Fukuzaki,et al.  Effects of hypoxia on sterol synthesis, acyl-CoA:cholesterol acyltransferase activity, and efflux of cholesterol in cultured rabbit skin fibroblasts. , 1990, Arteriosclerosis.